🚀 VC round data is live in beta, check it out!
AngioDynamics Valuation Multiples
Discover revenue and EBITDA valuation multiples for AngioDynamics and similar public comparables like Medistim, Medmix, OrthoPediatrics, Imricor Medical Systems and more.
AngioDynamics Overview
About AngioDynamics
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.
Founded
1992
HQ
Employees
675
Website
Financials (LTM)
EV
$409M
AngioDynamics Financials
AngioDynamics reported last 12-month revenue of $312M and EBITDA of $12M.
In the same LTM period, AngioDynamics generated $169M in gross profit, $12M in EBITDA, and had net loss of ($15M).
Revenue (LTM)
AngioDynamics P&L
In the most recent fiscal year, AngioDynamics reported revenue of $293M and EBITDA of $8M.
AngioDynamics expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $312M | XXX | $293M | XXX | XXX | XXX |
| Gross Profit | $169M | XXX | $158M | XXX | XXX | XXX |
| Gross Margin | 54% | XXX | 54% | XXX | XXX | XXX |
| EBITDA | $12M | XXX | $8M | XXX | XXX | XXX |
| EBITDA Margin | 4% | XXX | 3% | XXX | XXX | XXX |
| EBIT Margin | (13%) | XXX | (8%) | XXX | XXX | XXX |
| Net Profit | ($15M) | XXX | ($6M) | XXX | XXX | XXX |
| Net Margin | (5%) | XXX | (2%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
AngioDynamics Stock Performance
AngioDynamics has current market cap of $449M, and enterprise value of $409M.
Market Cap Evolution
AngioDynamics' stock price is $10.87.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $409M | $449M | 0.0% | XXX | XXX | XXX | $-0.15 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialAngioDynamics Valuation Multiples
AngioDynamics trades at 1.3x EV/Revenue multiple, and 34.5x EV/EBITDA.
EV / Revenue (LTM)
AngioDynamics Financial Valuation Multiples
As of April 20, 2026, AngioDynamics has market cap of $449M and EV of $409M.
Equity research analysts estimate AngioDynamics' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
AngioDynamics has a P/E ratio of (29.6x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $449M | XXX | $449M | XXX | XXX | XXX |
| EV (current) | $409M | XXX | $409M | XXX | XXX | XXX |
| EV/Revenue | 1.3x | XXX | 1.4x | XXX | XXX | XXX |
| EV/EBITDA | 34.5x | XXX | 53.8x | XXX | XXX | XXX |
| EV/EBIT | (10.4x) | XXX | (17.0x) | XXX | XXX | XXX |
| EV/Gross Profit | 2.4x | XXX | 2.6x | XXX | XXX | XXX |
| P/E | (29.6x) | XXX | (74.6x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (28.1x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified AngioDynamics Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
AngioDynamics Margins & Growth Rates
AngioDynamics' revenue in the last 12 month grew by 5%.
AngioDynamics' revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.3M for the same period.
AngioDynamics' rule of 40 is 10% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
AngioDynamics' rule of X is 18% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
AngioDynamics Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 5% | XXX | 7% | XXX | XXX | XXX |
| EBITDA Margin | 4% | XXX | 3% | XXX | XXX | XXX |
| EBITDA Growth | (6%) | XXX | 64% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 10% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 18% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.4M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.3M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 35% | XXX | 35% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 14% | XXX | 14% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 9% | XXX | 9% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 62% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
AngioDynamics Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| AngioDynamics | XXX | XXX | XXX | XXX | XXX | XXX |
| Medistim | XXX | XXX | XXX | XXX | XXX | XXX |
| Medmix | XXX | XXX | XXX | XXX | XXX | XXX |
| OrthoPediatrics | XXX | XXX | XXX | XXX | XXX | XXX |
| Imricor Medical Systems | XXX | XXX | XXX | XXX | XXX | XXX |
| CellaVision | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
AngioDynamics M&A Activity
AngioDynamics acquired XXX companies to date.
Last acquisition by AngioDynamics was on XXXXXXXX, XXXXX. AngioDynamics acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by AngioDynamics
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialAngioDynamics Investment Activity
AngioDynamics invested in XXX companies to date.
AngioDynamics made its latest investment on XXXXXXXX, XXXXX. AngioDynamics invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by AngioDynamics
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout AngioDynamics
| When was AngioDynamics founded? | AngioDynamics was founded in 1992. |
| Where is AngioDynamics headquartered? | AngioDynamics is headquartered in United States. |
| How many employees does AngioDynamics have? | As of today, AngioDynamics has over 675 employees. |
| Who is the CEO of AngioDynamics? | AngioDynamics' CEO is James C. Clemmer. |
| Is AngioDynamics publicly listed? | Yes, AngioDynamics is a public company listed on Nasdaq. |
| What is the stock symbol of AngioDynamics? | AngioDynamics trades under ANGO ticker. |
| When did AngioDynamics go public? | AngioDynamics went public in 2004. |
| Who are competitors of AngioDynamics? | AngioDynamics main competitors are Medistim, Medmix, OrthoPediatrics, Imricor Medical Systems. |
| What is the current market cap of AngioDynamics? | AngioDynamics' current market cap is $449M. |
| What is the current revenue of AngioDynamics? | AngioDynamics' last 12 months revenue is $312M. |
| What is the current revenue growth of AngioDynamics? | AngioDynamics revenue growth (NTM/LTM) is 5%. |
| What is the current EV/Revenue multiple of AngioDynamics? | Current revenue multiple of AngioDynamics is 1.3x. |
| Is AngioDynamics profitable? | Yes, AngioDynamics is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of AngioDynamics? | AngioDynamics' last 12 months EBITDA is $12M. |
| What is AngioDynamics' EBITDA margin? | AngioDynamics' last 12 months EBITDA margin is 4%. |
| What is the current EV/EBITDA multiple of AngioDynamics? | Current EBITDA multiple of AngioDynamics is 34.5x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.